Expert clinical manufacturing for sterile injectables
From your first clinical batches to phase 3 scale-up, we provide the support you need for every step in the development of your injectable drug product.
A trusted CDMO partner from clinical development to commercialization
During the clinical development cycle, your parenteral medication will take some of the most important and challenging steps in its evolution from promising molecule to life-changing therapy. To succeed with regulators, supply your clinical trials, and achieve the breakthrough in patient care, you need a responsive, collaborative CDMO who’s committed to meeting both critical timelines and the highest possible quality standards.
Vetter has the expertise, experience, and cutting-edge clinical manufacturing services you need from that critical partner. We fill clinical-stage products in a range of vials, syringes, and cartridges, with flexible processes and supporting services that scale with your product’s development – from clinical batches and their regulatory pathways to a secure global supply of your product.
Why Vetter for clinical manufacturing
Manufacturing services for clinical-phase products
We offer the end-to-end support for key fill and finish processes at every step of your product’s development. Our clinical trial manufacturing services include:
- Compounding
- Filtration
- Preparation of primary packaging materials
- Aseptic filling
- Lyophilization for clinical trial materials
- Terminal sterilization
- Visual inspection
- Stability testing
Support for a wide range of complex molecules
Our team and facilities are ready to fill a broad spectrum of substance classes, including:
- Oligonucleotides
- Monoclonal antibodies
- Fusion proteins
- Peptide hormones
- Coagulation factors
- Many more sensitive molecules
Advancing clinical programs around the world
Today’s drug development initiatives need to reach diverse patient populations at points of care worldwide. We currently support active clinical trials on three continents, and have the expertise, resources, and supply chains to help your clinical program achieve truly global scale.
We are excited to work with such a high quality and reliable partner. With Vetter’s world-class support, we can further strengthen the supply chain for our novel drug sonelokimab from filling of syringes and subsequent assembly into an autoinjector combination device and packaging.
Oliver Daltrop, Chief Technical Officer, MoonLake
Vetter’s expertise and uncompromising quality have contributed to our success, even under our agggressive timelines. It has been a pleasure working with the Vetter Teams in Chicago and Germany.
Ron Tetreault, Director of CMC, Agenus, Inc.
At a glance
80 %
of our active customer projects involve complex biologics
190 +
active customer projects in preclinical through Phase III
9
product launches in 2022
70 %
of customers with clinical projects have <200 employees
Our investments
Expanding our support for your clinical success
We’re actively expanding our clinical manufacturing services through continual investment in expertise, resources, and capacity. Today, we have dedicated facilities in both the US and EU, providing specialized aseptic filling support for customers and their clinical trials around the world.
Our facilities
Global know-how, experience, and technology
Curious to see where many life-changing injectable medications are made?
Take a 360-degree virtual tour of our world-class facilities.
